WebMar 22, 2024 · NEW YORK and BERLIN, Jan. 06, 2024 (GLOBE NEWSWIRE) — atai … WebMar 14, 2024 · Atai Life Sciences N.V. (NASDAQ:ATAI)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.12. Considering analysts have assigned the stock a price target range of $5.10-$21.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $12.51.
Atai Life Sciences - ATAI News Today - MarketBeat
WebApr 12, 2024 · 5 brokers have issued 1 year price objectives for Atai Life Sciences' stock. … WebFounded. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company, which engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2024 and is headquartered in Berlin, Germany. florida waiting children photolisting
ATAI Life Sciences Stock (NASDAQ:ATAI), Quotes and News Summary …
WebATAI Complete ATAI Life Sciences N.V. stock news by MarketWatch. View real-time … WebApr 14, 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 5 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ... WebJan 12, 2024 · After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche florida wage statement form